Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Inhibikase Therapeutics, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Net income  -5.8-4.5-4.3-4.5-4.6-4.6-5.0-4.5
Depreciation and amortization   [+]0.20.00.00.0    
Stock-based compensation  0.10.1-0.40.40.10.1-1.31.3
Change in working capital   [+]0.4-1.8-0.7-0.60.51.02.7-1.0
Other operating activities  0.50.21.8-0.8-0.4-0.4-0.52.2
Cash from operations  -4.6-6.0-3.6-5.5-4.4-3.9-4.1-2.0
   
Capital expenditures  0.00.00.5-0.30.00.00.00.0
Purchases of short-term investments  2.9-21.641.5-20.7    
Other cash from investing  -0.415.8-37.00.1    
Cash from investing  2.5-5.85.0-20.90.00.00.00.0
   
Issuance of common stock, net  0.08.6     0.0
Option exercises       0.0 0.0
Other cash from financing       -0.2 0.1
Cash from financing  0.08.60.00.00.0-0.20.00.0
   
Free cash flow  -4.6-6.0-3.1-5.8-4.4-3.9-4.1-2.0
        Per share (diluted)  ($0.88)($0.22)($0.12)($0.23)($1.04)($0.16)($0.22)($0.08)
   
Cash paid for interest       0.00.0 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy